"T-Lymphocytes" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Lymphocytes responsible for cell-mediated immunity. Two types have been identified - cytotoxic (T-LYMPHOCYTES, CYTOTOXIC) and helper T-lymphocytes (T-LYMPHOCYTES, HELPER-INDUCER). They are formed when lymphocytes circulate through the THYMUS GLAND and differentiate to thymocytes. When exposed to an antigen, they divide rapidly and produce large numbers of new T cells sensitized to that antigen.
| Descriptor ID |
D013601
|
| MeSH Number(s) |
A11.118.637.555.567.569 A15.145.229.637.555.567.569 A15.382.490.555.567.569
|
| Concept/Terms |
T-Lymphocytes- T-Lymphocytes
- T Lymphocytes
- T-Lymphocyte
- T-Cells
- T Cells
- T-Cell
- Thymus-Dependent Lymphocytes
- Lymphocyte, Thymus-Dependent
- Lymphocytes, Thymus-Dependent
- Thymus Dependent Lymphocytes
- Thymus-Dependent Lymphocyte
|
Below are MeSH descriptors whose meaning is more general than "T-Lymphocytes".
Below are MeSH descriptors whose meaning is more specific than "T-Lymphocytes".
This graph shows the total number of publications written about "T-Lymphocytes" by people in this website by year, and whether "T-Lymphocytes" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 14 | 9 | 23 |
| 1996 | 8 | 6 | 14 |
| 1997 | 13 | 7 | 20 |
| 1998 | 15 | 6 | 21 |
| 1999 | 18 | 10 | 28 |
| 2000 | 4 | 9 | 13 |
| 2001 | 19 | 7 | 26 |
| 2002 | 16 | 17 | 33 |
| 2003 | 20 | 12 | 32 |
| 2004 | 18 | 12 | 30 |
| 2005 | 10 | 9 | 19 |
| 2006 | 17 | 6 | 23 |
| 2007 | 16 | 13 | 29 |
| 2008 | 10 | 7 | 17 |
| 2009 | 18 | 16 | 34 |
| 2010 | 10 | 11 | 21 |
| 2011 | 18 | 9 | 27 |
| 2012 | 11 | 15 | 26 |
| 2013 | 21 | 12 | 33 |
| 2014 | 17 | 18 | 35 |
| 2015 | 23 | 17 | 40 |
| 2016 | 14 | 17 | 31 |
| 2017 | 12 | 10 | 22 |
| 2018 | 20 | 13 | 33 |
| 2019 | 14 | 8 | 22 |
| 2020 | 17 | 10 | 27 |
| 2021 | 8 | 13 | 21 |
| 2022 | 8 | 13 | 21 |
| 2023 | 7 | 14 | 21 |
| 2024 | 4 | 10 | 14 |
| 2025 | 5 | 1 | 6 |
To return to the timeline,
click here.
Below are the most recent publications written about "T-Lymphocytes" by people in Profiles.
-
Selection of therapeutically effective T-cell receptors from the diverse tumor-bearing repertoire. J Immunother Cancer. 2025 May 02; 13(5).
-
Mapping the extracellular molecular architecture of the pAg-signaling complex with a-Butyrophilin antibodies. Sci Rep. 2025 Apr 09; 15(1):12162.
-
Tet Methylcytosine Dioxygenase 2 (TET2) Mutation Drives a Global Hypermethylation Signature in Patients With Pulmonary Arterial Hypertension (PAH): Correlation With Altered Gene Expression Relevant to a Common T Cell Phenotype. Compr Physiol. 2025 Apr; 15(2):e70011.
-
Leveraging the Immunomodulatory Potential of Ibrutinib for Improved Outcomes of T Cell-Mediated Therapies of B Cell Malignancies: A Narrative Review. Target Oncol. 2025 Mar; 20(2):217-234.
-
Phase 1 clinical trial of B-Cell Maturation Antigen (BCMA) NEX-T® Chimeric Antigen Receptor (CAR) T cell therapy CC-98633/BMS-986354 in participants with triple-class exposed multiple myeloma. Leukemia. 2025 Apr; 39(4):816-826.
-
Analysis of Store-Operated Ca2+ Entry in Primary T Cells. Methods Mol Biol. 2025; 2904:91-113.
-
PSCA-targeted BPX-601 CAR T cells with pharmacological activation by rimiducid in metastatic pancreatic and prostate cancer: a phase 1 dose escalation trial. Nat Commun. 2024 12 30; 15(1):10743.
-
Central control of dynamic gene circuits governs T cell rest and activation. Nature. 2025 Jan; 637(8047):930-939.
-
CTLA4 blockade abrogates KEAP1/STK11-related resistance to PD-(L)1 inhibitors. Nature. 2024 Nov; 635(8038):462-471.
-
Ligand-induced segregation from large cell-surface phosphatases is a critical step in ?d TCR triggering. Cell Rep. 2024 09 24; 43(9):114761.